US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 1.995
  • +0.025+1.27%
Trading Jul 22 12:06 ET
244.11MMarket Cap-1781P/E (TTM)

Mersana Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q1
Stock NameRevenueRatio
Business of discovering and developing antibody-drug conjugates (ADCs)9.25M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.86M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg